Mizuho Asset Management Co. Ltd. Acquires 3,231 Shares of HCP Inc. (HCP)
Mizuho Asset Management Co. Ltd. raised its position in HCP Inc. (NYSE:HCP) by 100.5% during the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 6,447 shares of the real estate investment trust’s stock after buying an additional 3,231 shares during the period. Mizuho Asset Management Co. Ltd.’s holdings in HCP were worth $228,000 at the end of the most recent quarter.
Several other institutional investors have also bought and sold shares of HCP. Vanguard Group Inc. increased its stake in shares of HCP by 2.5% in the second quarter. Vanguard Group Inc. now owns 64,880,191 shares of the real estate investment trust’s stock valued at $2,295,461,000 after buying an additional 1,578,634 shares during the period. JPMorgan Chase & Co. boosted its position in HCP by 4.0% in the first quarter. JPMorgan Chase & Co. now owns 22,671,067 shares of the real estate investment trust’s stock valued at $738,623,000 after buying an additional 877,224 shares in the last quarter. BlackRock Institutional Trust Company N.A. boosted its position in HCP by 1.3% in the first quarter. BlackRock Institutional Trust Company N.A. now owns 18,210,535 shares of the real estate investment trust’s stock valued at $593,299,000 after buying an additional 227,354 shares in the last quarter. Daiwa Securities Group Inc. boosted its position in HCP by 8.0% in the second quarter. Daiwa Securities Group Inc. now owns 16,604,480 shares of the real estate investment trust’s stock valued at $587,467,000 after buying an additional 1,223,911 shares in the last quarter. Finally, BlackRock Fund Advisors boosted its position in HCP by 3.8% in the first quarter. BlackRock Fund Advisors now owns 15,129,139 shares of the real estate investment trust’s stock valued at $492,907,000 after buying an additional 547,335 shares in the last quarter. Institutional investors own 91.16% of the company’s stock.
Shares of HCP Inc. (NYSE:HCP) traded up 0.7300% during trading on Tuesday, reaching $37.7133. 249,012 shares of the company were exchanged. The stock has a 50-day moving average price of $38.89 and a 200-day moving average price of $35.55. The stock’s market capitalization is $17.63 billion. HCP Inc. has a one year low of $25.11 and a one year high of $40.43.
HCP (NYSE:HCP) last issued its quarterly earnings results on Tuesday, August 9th. The real estate investment trust reported $0.74 EPS for the quarter, topping the Zacks’ consensus estimate of $0.70 by $0.04. The firm had revenue of $662.20 million for the quarter, compared to analyst estimates of $631.25 million. HCP had a negative net margin of 2.52% and a negative return on equity of 0.67%. The business’s revenue for the quarter was up 9.0% compared to the same quarter last year. During the same quarter in the prior year, the firm earned $0.79 EPS. Analysts forecast that HCP Inc. will post $2.83 EPS for the current year.
The business also recently declared a quarterly dividend, which was paid on Tuesday, August 23rd. Stockholders of record on Monday, August 8th were issued a $0.575 dividend. This represents a $2.30 dividend on an annualized basis and a dividend yield of 6.14%. The ex-dividend date of this dividend was Thursday, August 4th. HCP’s payout ratio is -1,533.33%.
Several research analysts have recently commented on HCP shares. Argus reaffirmed a “hold” rating on shares of HCP in a report on Sunday. Mizuho increased their price target on shares of HCP from $32.00 to $37.00 and gave the stock a “neutral” rating in a research report on Wednesday, August 10th. Raymond James Financial Inc. began coverage on shares of HCP in a research report on Tuesday, July 26th. They set an “underperform” rating on the stock. BMO Capital Markets reiterated a “sell” rating on shares of HCP in a research report on Monday, June 20th. Finally, Barclays PLC lowered shares of HCP from an “equal weight” rating to an “underweight” rating and cut their target price for the company from $40.00 to $37.00 in a research report on Wednesday, June 1st. Seven analysts have rated the stock with a sell rating, ten have issued a hold rating and two have given a buy rating to the company’s stock. The company presently has a consensus rating of “Hold” and an average target price of $34.24.
In other news, EVP Jonathan M. Bergschneider sold 7,651 shares of the company’s stock in a transaction on Tuesday, August 23rd. The shares were sold at an average price of $39.78, for a total value of $304,356.78. Following the completion of the sale, the executive vice president now owns 54,095 shares of the company’s stock, valued at approximately $2,151,899.10. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. Also, insider Thomas D. Kirby sold 3,000 shares of the company’s stock in a transaction on Wednesday, September 7th. The shares were sold at an average price of $40.24, for a total transaction of $120,720.00. The disclosure for this sale can be found here. 0.22% of the stock is currently owned by insiders.
HCP, Inc (HCP) is a self-administered real estate investment trust (REIT). The Company invests in real estate serving the healthcare industry in the United States. Its portfolio consists of investments in various healthcare segments: senior housing, post-acute/skilled nursing, life science, medical office and hospital.
Want to see what other hedge funds are holding HCP? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for HCP Inc. (NYSE:HCP).
Receive News & Ratings for HCP Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCP Inc. and related companies with MarketBeat.com's FREE daily email newsletter.